CEO Message
It’s important to know the value of what you bring to the table each day, and at Xeedia, our value starts way before the molecule. Hardworking innovators pave our company’s success in the industry under a unified mindset of transformational solutions that improve the daily life of the average human.
It’s important to know the value of what you bring to the table each day, and at Xeedia, our value starts way before the molecule. Hardworking innovators pave our company’s success in the industry under a unified mindset of transformational solutions that improve the daily life of the average human.
Dr. Amr Desouky
CEO
Dr. Amr Desouky
Dr. Amr Desouky
CEO
Dr. Amr Desouky
CEO
Dr. Amr Desouky, a seasoned pharmaceutical leader with over two decades of experience and a proven track record in strategic leadership, sales, marketing, market access, and commercial management, has been instrumental in driving innovation and growth within the Egyptian pharmaceutical industry. His expertise in building high-performing teams and optimizing business strategies has positioned Xeedia as a leading player in the market, committed to improving patient care and contributing to the pharmaceutical industry’s growth in Egypt.
Mr. Ahmed Hamouda
Human Resources Director
Mr. Ahmed Hamouda
Human Resources Director
Ahmed Hamouda is a dedicated leader and corporate culture advocate with nearly two decades of experience in human resources. He has played a pivotal role in establishing Xeedia's HR department from the ground up, bringing deep expertise in organizational behavior, talent management, training and development, and process efficiency. A strategic player within the organization, he consistently aligns business objectives with HR strategies to drive growth and innovation. As a culture shaper, he fosters a collaborative, high-performance environment that empowers individuals and strengthens organizational values, ensuring Xeedia Pharma's long-term success and thriving corporate culture. Passionate about driving employee satisfaction and organizational growth, Mr. Hamouda has made significant contributions to Xeedia Pharmaceuticals' reputation as a branded top employer in the pharmaceutical market.
Mr. Ayman Aly Kashif
Finance Director
Mr. Ayman Aly Kashif
Finance Director
Since joining Xeedia Pharmaceuticals in September 2020, Mr. Ayman has played a pivotal role in shaping the company's financial policies and practices. With over two decades of experience, his leadership has been instrumental in securing bank facilities to support working capital and driving sales growth, contributing to Xeedia’s recognition among Egypt's top 100 pharmaceutical companies. He has a proven track record of enhancing financial performance, improving cash flow cycles, and implementing effective cost management strategies. He is dedicated to fostering strong relationships with stakeholders and ensuring compliance with regulatory requirements, all while leading and developing finance teams to support the company's strategic objectives.
Dr. Ahmed Mohsen
GCC Country Manager
Dr. Ahmed Mohsen
GCC Country Manager
Ahmed Mohsen brings a wealth of expertise to the pharmaceutical industry and has played a pivotal role in launching an innovative bladder cancer treatment featuring a new mechanism of action. Ahmed excels in building a patient-centric brand vision through an in-depth understanding of different therapeutic areas including cardiovascular, hematology, and oncology with a proven track record in commercial management with an MBA in Marketing from AAST and a bachelor’s degree in pharmacy from MUST, Ahmed combines his academic background with hands-on experience in product specialization, sales, and team management. His strategic vision and commitment to improving patient outcomes are integral to Xeedia's success in the GCC.
Dr. Dina Diaa
Marketing Manager
Dr. Dina Diaa
Marketing Manager
Dina Diaa joined Xeedia Pharmaceuticals in 2020 as a Product Manager, bringing with her a wealth of experience in the pharmaceutical industry. Her initial focus was on launching innovative products such as ZYROVAZET and EXEEDOLIP, where her ability to develop and implement strategic marketing plans resulted in rapid market penetration. These early successes showcased her strong leadership and product management skills, laying the foundation for her swift advancement within the company. Her hands-on experience in launching complex portfolios and her ability to foster strong relationships with Key Opinion Leaders (KOLs) made her a sought-after marketing leader in the industry. Now, as Xeedia’s Marketing Manager, Dina leverages her broad industry knowledge and strategic insight to drive the company’s marketing initiatives forward and continues to enhance Xeedia’s market presence, ensuring the company remains a trusted name in the pharmaceutical landscape.
Dr. Mohamed Zeidan
GCC Market Access & Government Affairs Director
Dr. Mohamed Zeidan
GCC Market Access & Government Affairs Director
Mohamed Zeidan brings extensive expertise and a strategic perspective shaped by over 15 years in the pharmaceutical industry, with a decade dedicated to market access leadership. Throughout his career, Zeidan has led market access across diverse healthcare systems in the Middle East and Africa, cultivating a profound understanding of the region’s unique challenges and opportunities with a focus on value-based healthcare. His strategic approach to markets has been shaped by applied experience across a range of therapeutic areas, including primary care, biologics, oncology, acute care, and women’s health. Zeidan is passionate and deeply committed to achieving the delicate balance between Xeedia’s business goals and its vision of addressing the evolving needs of patients and healthcare systems.
Dr. Mostafa Abd Elmonem
Compliance & Training Manager
Dr. Mostafa Abd Elmonem
Compliance & Training Manager
With a solid foundation in pharmaceutical sciences and an MBA in Marketing from AAST, Mostafa Abd Elmonem Elsayed brings over 15 years of experience in the pharmaceutical industry. He has held various leadership roles, managing product portfolios, driving sales growth, and leading teams to achieve outstanding results.Currently serving as Xeedia Pharma's National Training and Compliance Manager, Mostafa oversees training programs and ensures compliance excellence. His dedication to professional growth is reflected in advanced certifications in leadership and coaching, solidifying his reputation as a seasoned and inspiring leader.
Dr. Marwa Reda
GCC Supply Chain Manager
Dr. Marwa Reda
GCC Supply Chain Manager
Marwa Reda Lotfy is an accomplished pharmaceutical supply chain professional with over a decade of experience in supply chain management and foreign purchasing within the pharmaceutical industry. Marwa brings strategic expertise in managing and streamlining complex supply chains across Gulf Cooperation Council countries. She holds a Bachelor of Pharmaceutical Science with honors from Cairo University (2011). She has obtained certifications, including the APICS CPIM for supply chain management basics and a specialized Supply Chain Management diploma from the American University in Cairo. Marwa has a proven record of optimizing procurement processes, managing supplier relationships, and overseeing the timely delivery of raw and packaging materials.
Dr. Ahmed ElFouly
Medical Manager
Dr. Ahmed ElFouly
Medical Manager
Ahmed Elfouly is a Competent Medical Manager at Xeedia Pharmaceuticals, recognized for his leadership and analytical abilities. He began as a Medical Advisor and quickly advanced, playing a key role in identifying clinical treatment gaps and fostering long-term partnerships with healthcare professionals. Ahmed leads a high-performing medical team, ensuring effective clinical messaging and organizing CME programs. His focus on team collaboration and medical education has been vital to Xeedia's growth. He holds an MBA in Marketing from ESLSCA Business School and a Pharmaceutical Sciences degree from Helwan University.
If you come across a complex situation whether ethical, technical, or otherwise problematic, please bring it to our attention, and let's find the best way to make it right together.
Newsletter